How do I know if my thyroid is overactive?

Written and medically reviewed by Zahraa Sater, M.D., M.P.H.

Reviewed August 12, 2026 · Next review due August 12, 2028

Short answer

An overactive thyroid causes weight loss despite a good appetite, a fast or irregular heartbeat, tremor, heat intolerance, sweating, anxiety and frequent bowel movements. Diagnosis starts with a suppressed TSH plus a raised free T4 or total T3. Graves' disease is the most common cause and is confirmed with a TSH receptor antibody test.

Get urgent care if: an overactive thyroid is known or suspected and any of the following develop, which can indicate thyroid storm or agranulocytosis.

  • Fever with agitation, confusion or delirium
  • Heart rate persistently above 140, chest pain, or breathlessness at rest
  • Vomiting, diarrhoea and dehydration in someone with known thyrotoxicosis
  • Fever, sore throat or mouth ulcers while taking methimazole or propylthiouracil: stop the drug and get an urgent white cell count
  • Yellowing of the eyes or skin while taking propylthiouracil

An overactive thyroid, or thyrotoxicosis, speeds up systems that hypothyroidism slows down. The National Institute of Diabetes and Digestive and Kidney Diseases lists weight loss despite an increased appetite, rapid heartbeat, nervousness, tremor, excessive sweating, fatigue, muscle weakness, frequent bowel movements and goitre. Symptoms often build over weeks rather than months, and the cardiac ones bring most people in.

How an overactive thyroid is confirmed

The 2016 American Thyroid Association hyperthyroidism guideline recommends that serum TSH, free T4 and total T3 all be assessed at the initial evaluation of suspected thyrotoxicosis. TSH is suppressed first. Free T4, total T3 or both are then raised in overt disease. Where TSH is low but free T4 and T3 sit within their normal ranges, the picture is subclinical hyperthyroidism, which the same guideline defines exactly that way. Biotin supplements can create a false Graves' pattern on these assays, so they should be stopped before testing.

Finding the cause

Cause matters because treatment differs completely. Graves' disease is autoimmune and is confirmed by a positive TSH receptor antibody, which the 2016 guideline describes as cost effective because a positive result establishes the most common cause without further imaging. A toxic nodule or toxic multinodular goitre produces autonomous hormone output and is identified on a radionuclide uptake scan. Thyroiditis releases stored hormone from a damaged gland, shows low uptake, is usually self-limiting and does not respond to antithyroid drugs. Taking too much thyroid hormone, including hormone hidden in supplements, produces the same blood picture.

The three treatment routes

For Graves' disease there are antithyroid drugs, radioiodine and thyroidectomy. Methimazole is the preferred antithyroid drug outside the first trimester of pregnancy, where propylthiouracil is used instead. Anyone starting an antithyroid drug must be told about agranulocytosis: the 2016 guideline instructs that patients report fever, sore throat or mouth ulcers immediately and stop the drug pending a white cell count.

CauseDistinguishing testTypical treatment
Graves' diseasePositive TSH receptor antibody, diffuse uptakeMethimazole, radioiodine or surgery
Toxic nodule or multinodular goitreFocal uptake on radionuclide scanRadioiodine or surgery
ThyroiditisLow radioiodine uptakeBeta blocker, observation
Excess thyroid hormone intakeLow uptake, low thyroglobulin, medication or supplement historyStop the source

If you have palpitations with weight loss and heat intolerance, ask for TSH, free T4 and total T3 on the same draw, and bring every supplement bottle to the appointment. Untreated thyrotoxicosis causes atrial fibrillation and bone loss, so this is one thyroid problem that should not be watched indefinitely.

The clinical detail

Total T3 is preferred over free T3 assays for diagnosis. T3 toxicosis, where total T3 is raised while free T4 remains normal, occurs early in Graves' disease and with autonomous nodules, which is why the 2016 American Thyroid Association guideline specifies all three analytes at initial evaluation.

Subclinical hyperthyroidism is a low or undetectable TSH with normal free T4 and T3. The 2016 guideline strengthened its position, recommending treatment for patients aged 65 and over, those with cardiac risk factors or osteoporosis, postmenopausal women not on oestrogen or bisphosphonate therapy, and symptomatic patients. Radioiodine uptake is high in Graves' disease and low in thyroiditis or exogenous hormone ingestion; a suppressed thyroglobulin points to exogenous hormone. Beta blockers control adrenergic symptoms while the underlying cause is being determined.

Written and medically reviewed by Zahraa Sater, M.D., M.P.H.

Reviewed August 12, 2026 · Next review due August 12, 2028

Sources

  1. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. American Thyroid Association. PMID 27521067
  2. Hyperthyroidism (Overactive Thyroid). National Institute of Diabetes and Digestive and Kidney Diseases
  3. Hyperthyroidism. MedlinePlus, National Library of Medicine
  4. Biotin Interference with Thyroid Function Tests. American Thyroid Association, Clinical Thyroidology for the Public

Was this answer helpful?

This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.